Loading...
 
Translate Register Log In Login with facebookLogin and Register

Kidney failure 1.7X more likely - Vitamin D Binding Protein – Feb 2016


VitaminDWiki

The items in both categories: Kidney and Vitamin D Binding Protein:

Genetics category listing contains the following

245 articles in the Genetics category

see also 300 articles in Vitamin D Receptor, 113 articles in Vitamin D Binding Protein

Vitamin D blood test misses a lot
Blood Test Misses a lot (VDW 3439)

  • Snapshot of the literature by VitaminDWiki - (subject to many future developments)
  • Vitamin D from coming from tissues (vs blood) was speculated to be 50% in 2014, andi in 2017 is speculated to be 90%
  • Note: Good results from a blood test (> 40 ng) does not mean that a good amount of Vitamin D actually gets to cells
  • A Vitamin D test in cells appears feasible (personal communication)
    However test results would vary in each tissue due to multiple genes
  • Good clues that Vitamin D is being restricted from getting to the cells
    1) A vitamin D-related health problem runs in the family
       especially if it is one of 51+ diseases related to Vitamin D Receptor
    2) Slightly increasing Vitamin D show benefits (even if conventional Vitamin D test shows an increase)
    3) Vitamin D Receptor test (<$30) scores are difficult to understand in 2016
        easier to understand the VDR 23andMe test results analyzed by FoundMyFitness in 2018
    4) Back Pain
        probably want at least 2 clues before taking adding vitamin D, Omega-3, Magnesium, Resveratrol, etc
          The founder of VitaminDWiki took action with clues #3&4

Biomarkers of Vitamin D Status and Risk of ESRD - Feb 2016

American Journal of Kidney Diseases, Volume 67, Issue 2, February 2016, Pages 235–242, doi:10.1053/j.ajkd.2015.08.026
Casey M. Rebholz, PhD, MS, MPH1, , , Morgan E. Grams, MD, PhD, MHS1, 2, Pamela L. Lutsey, PhD, MPH3, Andrew N. Hoofnagle, MD, PhD4, Jeffrey R. Misialek, MPH3, Lesley A. Inker, MD, MS5, Andrew S. Levey, MD5, Elizabeth Selvin, PhD, MPH1, 6, Chi-yuan Hsu, MD, MSc7, Paul L. Kimmel, MD8, Ramachandran S. Vasan, MD9, 10, John H. Eckfeldt, MD, PhD11, Josef Coresh, MD, PhD, MHS1, 6, on behalf of the Chronic Kidney Disease Biomarkers
Background: Disordered mineral metabolism is characteristic of decreased kidney function. However, the prospective associations between circulating levels of vitamin D binding protein, vitamin D, and end-stage renal disease (ESRD) have not been extensively evaluated in epidemiologic studies.

Study Design: Nested case-control study.

Setting & Participants: Middle-aged black and white men and women from 4 US communities.

Predictors: Baseline levels of vitamin D binding protein, 25-hydroxyvitamin D (25[OH]D), and 1,25-dihydroxyvitamin D (1,25[OH]2D) were measured in blood samples collected at study visit 4 (1996-1998) of the ARIC (Atherosclerosis Risk in Communities) Study.

Outcome: ESRD cases (n = 184) were identified through hospitalization diagnostic codes from 1996 to 2008 and were frequency matched to controls (n = 251) on categories of estimated glomerular filtration rate, albuminuria, diabetes mellitus, sex, and race.

Measurements: Logistic regression was used to estimate the association between mineral metabolism biomarkers (vitamin D binding protein, 25(OH)D, and 1,25(OH)2D) and incident ESRD, adjusting for age, sex, race, estimated glomerular filtration rate, albuminuria, diabetes mellitus, hypertension, education, specimen type, and serum levels of calcium, phosphate, and parathyroid hormone.

Results: Higher vitamin D binding protein levels were associated with elevated risk for incident ESRD (OR, 1.76; 95% CI, 1.22-2.54; P = 0.003).
Higher free and bioavailable 25(OH)D levels were associated with reduced risk for incident ESRD (ORs of 0.65 [95% CI, 0.46-0.92; P = 0.02] and 0.63 [95% CI, 0.43-0.91; P = 0.02] for free and bioavailable 25[OH]D, respectively). There was no association between ESRD and overall levels of 25(OH)D (OR, 0.83; 95% CI, 0.58-1.19; P = 0.3) or 1,25(OH)2D (OR, 0.73; 95% CI, 0.48-1.13; P = 0.2).

Limitations: Lack of direct measurement of free and bioavailable vitamin D.

Conclusions: In the general population, blood levels of vitamin D binding protein were positively associated and blood levels of free and bioavailable 25(OH)D were inversely associated with new-onset ESRD during follow-up.

PDF is available free at Sci-Hub  10.1053/j.ajkd.2015.08.026


Kideny Cancer 3X more likely if poor Vitamin D Binding Protein - July 2018

Vitamin D binding protein and risk of renal cell carcinoma in the Cancer Prevention Study-II Cohort
Alison M. Mondul, Stephanie J. Weinstein, Dominick Parisi, Caroline Y Um, Marjorie L McCollough and Demetrius Albanes
DOI: 10.1158/1055-9965.EPI-18-0263

Background:Kidney cancer has several well-established risk factors including smoking, obesity, and hypertension. These factors do not, however, completely account for its etiology. One previous study of vitamin D binding protein (DBP) and risk of renal cell carcinoma found a striking inverse association that warranted replication. Methods:We conducted a nested case-control study in the American Cancer Society Cancer Prevention Study-II (CPS-II) Nutrition Cohort to prospectively examine circulating DBP concentration and renal cell carcinoma risk. Cases (n=87) were matched 1:1 to controls on gender, race, age (+/- 5 years), and date of blood collection (+/- 30 days). Odds ratios and 95% confidence intervals were estimated for quartiles of DBP using conditional logistic regression.

Results:There was a statistically significant inverse trend across quartiles of DBP (p-trend = 0.03) such that participants with higher DBP had a markedly decreased risk of renal cell carcinoma (vs. Q1: Q2 OR=0.93, 95% CI=0.41 - 2.11; Q3 OR=0.42, 95% CI=0.15 - 1.15; Q4 OR = 0.33, 95% CI=0.10 - 1.06; p-trend=0.03).

Conclusions:Our findings demonstrate a strong inverse association between circulating DBP and risk of renal cell carcinoma, supporting the findings from previous research. Impact:This is only the second study to examine vitamin D binding protein (DBP) and risk of kidney cancer, and one of only a handful of studies to examine circulating DBP and risk of cancer at any site. Our findings support emerging evidence for an etiologic role of DBP in cancer and may provide insights into the etiology of kidney and other cancers.

PDF is available free at Sci-Hub  10.1158/1055-9965.EPI-18-0263

See any problem with this page? Report it (FINALLY WORKS)